China may allow more pharmaceutical companies to produce traditional Chinese medicine granule on the basis of long-time pilot program, said a report by China Securities Journal on Tuesday. The government is soliciting suggestions on a draft of the Administration Rules on Traditional Chinese Medicine Formula Granule.
Medicine makers could start production after obtaining regulatory approval and amending their own medicine production license, according to the draft. China Food and Drug Administration issued a temporary administration document in this regard in 2001 and approved six companies to produce traditional Chinese medicine granule via a pilot program.
Latest comments